About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 4NCT01079312

Patient-controlled Sedation With Propofol and Remifentanyl for Endoscopic Retrograde Cholangiopancreatography (ERCP)

Background: Deep sedation with propofol and opioid is commonly used for endoscopic retrograde cholangiopancreatography (ERCP), but is associated with increased morbidity and mortality. Delivery of pro...

Lead sponsor: Helsinki University Central Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Helsinki University Central Hospital

80 elective ERCP patients were randomized to anaesthesiologist managed propofol sedation (PI-group) or PCS with propofol/remifentanil (PCS-group). Sedation degree was estimated every 5 min throughout the procedure using Ramsay´s and Gillham´s sedation scores. Total amount of propofol was calculated at the end of procedure. Endoscopists´ and patients´ satisfaction was evaluated with questionary.

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•elective ERCP-patients

Exclusion Criteria

•allergy to propofol or opioid;
•ASA-class (American Society of Anaesthesiology) greater than 3;
•inability to co-operate;
•drugs abuse.

Related studies

TEAS for Sedation During ERCP: A Multicenter Trial

NCT07440342 · Endoscopic Retrograde Cholangiopancreatography, Conscious Sedation Adverse Event, and more

Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic Sphincterotomy for Difficult Cannulation?

NCT04408482 · Endoscopic Retrograde Cholangiopancreatography

Effect of Deep Analgosedation vs. Endotracheal Intubation General Anesthesia on on Perioperative Sedation Related Adverse Events in Elderly ERCP Patients

NCT07017283 · Biliary and Pancreatic Diseases, Endoscopic Retrograde Cholangiopancreatography (ERCP)

COMPLETEDPhase 4

Adjunct Sedatives in Endoscopic Ultrasound (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures

NCT00937924 · Endoscopic Ultrasound (EUS), Endoscopic Retrograde Cholangiopancreatography (ERCP)

a Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Complication

NCT06277414 · Endoscopic Retrograde Cholangiopancreatography

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 22, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment80

Start dateJan 2009

Last updatedDec 22, 2020

Condition

Endoscopic Retrograde Cholangiopancreatography

Locations shown

Helsinki University Central Hospital,Meilahti hospital,Endoscopy unit

Helsinki, Uusimaa

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 22, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions